Literature DB >> 18947015

Macrophage activation syndrome as initial presentation of systemic lupus erythematosus.

Say-Tin Yeap1, Jiunn-Ming Sheen, Ho-Chang Kuo, Kao-Pin Hwang, Kuender D Yang, Hong-Ren Yu.   

Abstract

Macrophage activation syndrome (MAS) is known to be a severe and potentially life-threatening complication of rheumatic disorder, especially systemic juvenille rheumatoid arthritis. It is very rare for MAS to be an initial presentation of systemic lupus erythematosus (SLE). Here, we report a 14-year-old girl in whom MAS developed as an initial presentation of SLE. With early diagnosis and administration of cyclosporine A, she had a fair outcome. Further testing showed positive anti-dsDNA about 8 months later.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18947015     DOI: 10.1016/S1875-9572(08)60010-8

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  5 in total

1.  Association of Macrophage Activating Syndrome with Castleman's Syndrome in Systemic Lupus Erythematosus.

Authors:  Shamsa Shariatpanahi; Shahryar Pourfarzam; Mohammadhosein Gheini
Journal:  Iran J Pathol       Date:  2016

2.  Macrophage Activation Syndrome: A Report of Two Cases and a Literature Review.

Authors:  Asaad Alkoht; Ibrahem Hanafi; Basheer Khalil
Journal:  Case Rep Rheumatol       Date:  2017-10-25

3.  Hemophagocytic Syndrome as an Initial Presentation of Systemic Lupus Erythematosus: A Case Report.

Authors:  Mohammed AlSheef; Abdul Rehman Z Zaidi; AbdulAziz A AlAtmi; Lina H AlSharif; Arshad Mian
Journal:  Cureus       Date:  2019-07-29

4.  Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus: A Systematic Review of the Diagnostic Aspects.

Authors:  Altynay Abdirakhmanova; Vitaliy Sazonov; Zaure Mukusheva; Maykesh Assylbekova; Diyora Abdukhakimova; Dimitri Poddighe
Journal:  Front Med (Lausanne)       Date:  2021-06-04

Review 5.  Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review.

Authors:  Soamarat Vilaiyuk; Nongnuch Sirachainan; Suthep Wanitkun; Kwanchai Pirojsakul; Jarin Vaewpanich
Journal:  Clin Rheumatol       Date:  2013-03-13       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.